The MYC oncogene is a well-documented driver of tumorigenesis in many cancers, and the type-1 interferon pathway is an important pathway in the antiviral response; however, their roles in the formation of the tumor immunosuppressive microenvironment remain unclear. Here, MYC is linked to cancer.